Cipla informs about Press Release

23 Mar 2015 Evaluate

Cipla has informed regarding a Press Release dated March 23, 2015 titled 'Stempeutics receives Advanced Therapy Medicinal Product (ATMP) classification from European Medicines Agency (EMA) for its novel stem cell drug 'Stempeucel' '.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1497.95 6.55 (0.44%)
31-Dec-2025 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.75
Dr. Reddys Lab 1265.15
Cipla 1497.95
Zydus Lifesciences 911.20
Lupin 2091.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×